A double-blind, randomized, placebo-controlled clinical trial to investigate the effect of fermented milk containing Lactobacillus gasseri SBT2055 (LG2055) on fecal fat excretio
Not Applicable
- Conditions
- Healthy Adult
- Registration Number
- JPRN-UMIN000015772
- Lead Sponsor
- ew drug research center, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Subjects who have frequency of defecation less than 5 days a week 2) Subjects who regularly ingest fermented milk 3) Subject with a history of allergy to medicine and food 4) Subjects who have severe internal organ disorders including coronary heart disease, respiratory impairment, endocrinopathy, or defective metabolism 5) Subjects who have a history of major surgery of digestive system 6) Subjects who consume special health-promoting foods, took medication known to alter lipid metabolism 7)Subject who is judged to be ineligible due to subject's background, physical findings, medical examination, physical and clinical examination by principal investigator or sub investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method